ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; Pension and retirement benefit issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
Immigration IMM
Administration Immigration Proclamation on non-immigrant visa categories
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
Consumer Issues/Safety/Products CSP
Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BURKHEAD | — |
| HEATHER CLARK | — |
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
| DAVID TALBOT | — |
Trade (domestic/foreign) TRD
Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-Kenta, and US-Brazil
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BURKHEAD | — |
| HEATHER CLARK | — |
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
| DAVID TALBOT | — |
Copyright/Patent/Trademark CPT
Pharmaceutical intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
Health Issues HCR
Patient protection; Drug supply chain and shortages; Drug pricing, value and access; Transparency; Intellectual property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act"; American Rescue Plan Act, 2021 (HR.1319)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
Medicare/Medicaid MMM
Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage and value; Developing an Innovative Strategy for Antimicrobial Resistant Microorganism Act of 2019 (DISARM Act); American Rescue Plan Act, 2021 (HR.1319)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| SHAWN O'NEAIL | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
Pharmacy PHA
Hospital discounts; 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE | — |
| THOMAS CORDREY ROBERGE | Legislative Counsel (2002-2004 - Senator Peter Fitzgerald) |
| SHANNON STEHOUWER | Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014) |
| ASKIA SURUMA New | Chief of Staff, Rep. Marc Veasey (2017-2021); Deputy Staff Director, Ways and Means Committee (2007-2014); Deputy Staff Director, House Rules Committee (2001-2007); Legislative Director, Rep. Martin Frost (2000-2001) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.